Thermo Fisher Scientific Inc. (NYSE:TMO) inked a five-year supply deal with Eli Lilly & Co. (NYSE:LLY) that will see it take over some of the pharma giant’s clinical trial operations in Indianapolis.

Waltham, Mass.-based Thermo Fisher said its Fisher Clinical Services subsidiary will take over Lilly’s in-house clinical trial materials manufacturing, packaging and labeling operations in the Circle City. That transition should be done some time this summer, and by the end of the year TMO will have taken over the clinical trial materials distribution throughout North America.

Thermo Fisher said it will buy Lilly’s clinical trial manufacturing and packaging equipment as part of the deal. Lilly employees affected by the deal will be able to apply for jobs with Fisher Clinical Services, according to a press release.